Literature DB >> 7204567

Complement-derived chemotactic activity is generated in human serum containing uroporphyrin after irradiation with 405 nm light.

H W Lim, H D Perez, I M Goldstein, I Gigli.   

Abstract

Patients with porphyrias have varying degrees of photosensitivity, associated with elevated levels of porphyrins in plasma, erythrocyte, urine and/or feces. To investigate the role of complement in the pathogenesis of cutaneous lesions, varying amounts of uroporphyrin were added to normal human serum (0.1-10 microgram/ml), and the mixtures were then exposed to 405 nm irradiation. Such treatments result in the diminution of total hemolytic complement activity and hemolytic titers of C1, C4, C2, C3, and C5; furthermore, cleavage products of C3 and C5 were detected. Chemotactic activity for human polymorphonuclear leukocytes was generated that was inhibitable by incubation with anti-C5, but not with anti-C3 antisera. No chemotactic activity was generated in Mg++-EGTA treated serum nor in C4-deficient guinea pig serum. These data indicate that irradiation with 405 nm light of normal human serum containing uroporphyrin results in activation of the complement system via the classical pathway, and the generation of complement (C5)-derived chemotactic activity for human polymorphonuclear leukocytes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7204567      PMCID: PMC370666          DOI: 10.1172/jci110119

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  Erythropoietic protoprophyria--submicroscopic events during the acute photosensitivity flare.

Authors:  F G Schnait; K Wolff; K Konrad
Journal:  Br J Dermatol       Date:  1975-05       Impact factor: 9.302

2.  Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients.

Authors:  M E Grossman; D R Bickers; M B Poh-Fitzpatrick; V A Deleo; L C Harber
Journal:  Am J Med       Date:  1979-08       Impact factor: 4.965

3.  Cutaneous changes in the porphyrias. A microscopic study.

Authors:  J H Epstein; D L Tuffanelli; W L Epstein
Journal:  Arch Dermatol       Date:  1973-05

4.  Inhibition of the alternative pathway of human complement in vitro by a natural microbial product, complestatin.

Authors:  I Kaneko; D T Fearon; K F Austen
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

5.  The complement system in necrotizing angiitis of the skin. Analysis of complement component activities in serum of patients with concomitant collagen-vascular diseases.

Authors:  N A Soter; K F Austen; I Gigli
Journal:  J Invest Dermatol       Date:  1974-08       Impact factor: 8.551

6.  Prosser White Oration 1978. The complement system in inflammation and host defence.

Authors:  I Gigli
Journal:  Clin Exp Dermatol       Date:  1979-09       Impact factor: 3.470

7.  Penetration of epidermis by ultraviolet rays.

Authors:  M A Everett; E Yeargers; R M Sayre; R L Olson
Journal:  Photochem Photobiol       Date:  1966-07       Impact factor: 3.421

8.  Mouse model for protoporphyria. III. Experimental production of chronic erythropoietic protoporphyria-like skin lesions.

Authors:  H Hönigsmann; F Gschnait; K Konrad; G Stingi; K Wolff
Journal:  J Invest Dermatol       Date:  1976-03       Impact factor: 8.551

9.  A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.

Authors:  H D Perez; M Lipton; I M Goldstein
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

10.  Erythropoietic protoporphyria: lipid peroxidation and red cell membrane damage associated with photohemolysis.

Authors:  B D Goldstein; L C Harber
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808

View more
  7 in total

Review 1.  Photosensitivity due to drugs.

Authors:  J H Epstein; B U Wintroub
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

Review 2.  The role of complement in phototoxic reactions.

Authors:  H Lim; I Gigli
Journal:  Springer Semin Immunopathol       Date:  1981

3.  Activation of complement by 405-nm light in serum from porphyria cutanea tarda.

Authors:  W Torinuki; T Miura; H Tagami
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

4.  Activation of factor XII-dependent pathways in human plasma by hematin and protoporphyrin.

Authors:  C G Becker; M Wagner; A P Kaplan; M Silverberg; R W Grady; H Liem; U Muller-Eberhard
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

5.  Role of complement and polymorphonuclear cells in demethylchlortetracycline-induced phototoxicity in guinea pigs. Inhibition by decomplementation in vivo.

Authors:  H W Lim; H Novotny; I Gigli
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

6.  Activation of the complement system in patients with porphyrias after irradiation in vivo.

Authors:  H W Lim; M B Poh-Fitzpatrick; I Gigli
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

Review 7.  Recognized and Emerging Features of Erythropoietic and X-Linked Protoporphyria.

Authors:  Elena Di Pierro; Francesca Granata; Michele De Canio; Mariateresa Rossi; Andrea Ricci; Matteo Marcacci; Giacomo De Luca; Luisa Sarno; Luca Barbieri; Paolo Ventura; Giovanna Graziadei
Journal:  Diagnostics (Basel)       Date:  2022-01-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.